University of Maryland Medical System Series 2025A-B Revenue Bonds Assigned 'A' Rating

NEW YORK (S&P Global Ratings) Dec. 23, 2024--S&P Global Ratings assigned its 'A' long-term rating to the Maryland Health and Higher Education Facilities Authority's (MHHEFA) $226 million series 2025A and $62.6 million series 2025B health care revenue bonds, issued on behalf of University of Maryland Medical System (UMMS). We affirmed our 'A' long-term rating on various health care revenue bonds outstanding issued on behalf of UMMS. We also affirmed our joint 'AA+/A-1' rating on MHHEFA's series 2008D variable-rate revenue bonds, which reflects the application of our low-correlation joint criteria. The outlook on the long-term rating is stable. "The rating reflects UMMS' favorable enterprise profile, characterized by a sound business position as one of Maryland's leading health systems, with a large

...December 23, 2024 NEW YORK (S&P Global Ratings) Dec. 23, 2024--S&P Global Ratings assigned its 'A' long-term rating to the Maryland Health and Higher Education Facilities Authority's (MHHEFA) $226 million series 2025A and $62.6 million series 2025B health care revenue bonds, issued on behalf of University of Maryland Medical System (UMMS). We affirmed our 'A' long-term rating on various health care revenue bonds outstanding issued on behalf of UMMS. We also affirmed our joint '##+/A-1' rating on MHHEFA's series 2008D variable-rate revenue bonds, which reflects the application of our low-correlation joint criteria. The outlook on the long-term rating is stable. "The rating reflects UMMS' favorable enterprise profile, characterized by a sound business position as one of Maryland's leading health systems, with a large physician network and strong clinical programs, leveraging its relationship with the University of Maryland's School of Medicine," said S&P Global Ratings credit analyst Stephen...

Ratings Action